Clinical Trial

Using Social Influencers for Public Health Education on Antibiotic Use and Antimicrobial Resistance

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to compare the effectiveness of health education facilitated by neighborhood food and beauty establishments with that facilitated by clinics in increasing the public's knowledge of antibiotic use and antimicrobial resistance (AMR) and improving antibiotic behaviors. The quasi-experimental study will involve a total of 3300 patrons of the 10 most popular consenting clinics, food and beauty establishments respectively, in two neighborhoods in Singapore. Recruitment Process 1. Participants will scan the QR code on the posters in the participating clinics/establishments 2. Read the study information sheet 3. Consent will be implied on submission of survey 4. Total recruitment period: One year 5. Target: 3300 patrons of the 30 establishments (10 each of clinics, food, and beauty establishments) Intervention Structure 1. Participants will complete a pre-intervention/baseline survey (#1) 2. Intervention includes an animated educational video with key messages on appropriate antibiotic use and AMR 3. Followed by immediate post-intervention survey (#2) 4. Provide contact details (mobile phone number) for reimbursement \& future follow-up online surveys 5. Complete follow-up online surveys: at 1 month post-intervention (#3), 3 months post-intervention (#4) and 6 months post-intervention (#5) Expected Outcomes Increase in public knowledge of antibiotic use and AMR, and antibiotic behaviors through health education facilitated by neighborhood food and beauty establishments, in addition to that facilitated by clinics
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-22; most recent amendment 2025-07-28.
Status change: Not Yet Recruiting → Recruiting 2025-07-28
Trial Details
NCT Number NCT06998576
Lead Sponsor Tan Tock Seng Hospital
Conditions Community Members
Enrollment 3,300 participants
Start Date 2025-07-21
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-07-29